103 related articles for article (PubMed ID: 30135292)
1. [A Case of Bone Marrow Metastasis of Oligodendroglioma with IDH Mutation and 1p/19q Codeletion].
Kiko K; Suyama K; Yamamoto K; Mochida H; Oya S; Karasawa H; Watanabe S; Suzuki Y
No Shinkei Geka; 2018 Aug; 46(8):699-706. PubMed ID: 30135292
[TBL] [Abstract][Full Text] [Related]
2. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
[TBL] [Abstract][Full Text] [Related]
3. 1p/19q chromosome deletions in metastatic oligodendroglioma.
Merrell R; Nabors LB; Perry A; Palmer CA
J Neurooncol; 2006 Nov; 80(2):203-7. PubMed ID: 16710746
[TBL] [Abstract][Full Text] [Related]
4. Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.
Demeulenaere M; Duerinck J; DU Four S; Fostier K; Michotte A; Neyns B
Anticancer Res; 2016 Aug; 36(8):4145-9. PubMed ID: 27466523
[TBL] [Abstract][Full Text] [Related]
5. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B
Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340
[TBL] [Abstract][Full Text] [Related]
6. Leukemia-like onset of bone marrow metastasis from anaplastic oligodendroglioma after 17 years of dormancy: an autopsy case report.
Tanaka Y; Nobusawa S; Ikota H; Yokoo H; Hirato J; Ito H; Saito T; Ogura H; Nakazato Y
Brain Tumor Pathol; 2014 Apr; 31(2):131-6. PubMed ID: 23900511
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic oligodendroglioma metastasizing to the bone marrow: a unique case report and literature review.
Singh VK; Singh S; Bhupalam L
Int J Neurosci; 2019 Jul; 129(7):722-728. PubMed ID: 30526175
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
Hata N; Shono T; Mizoguchi M; Matsumoto K; Guan Y; Nagata S; Hayashi K; Iwaki T; Sasaki T
Neurol Res; 2007 Oct; 29(7):723-6. PubMed ID: 17553214
[TBL] [Abstract][Full Text] [Related]
10. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
[TBL] [Abstract][Full Text] [Related]
11. Metastatic oligodendroglioma: a case report and incidence in The Netherlands.
Krijnen JL; Fleischeur RE; van Berkel M; Westenend PJ
Clin Neuropathol; 2010; 29(3):141-6. PubMed ID: 20423687
[TBL] [Abstract][Full Text] [Related]
12. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.
Cahill DP; Louis DN; Cairncross JG
CNS Oncol; 2015; 4(5):287-94. PubMed ID: 26545048
[TBL] [Abstract][Full Text] [Related]
13. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.
Li G; Zhang Z; Zhang J; Jin T; Liang H; Gong L; Cui G; Yang H; He S; Zhang Y; Gao G
Diagn Pathol; 2014 Jan; 9():17. PubMed ID: 24447608
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
15. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
[TBL] [Abstract][Full Text] [Related]
17. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.
Michotte A; Chaskis C; Sadones J; Veld PI; Neyns B
J Neurol Sci; 2009 Dec; 287(1-2):267-70. PubMed ID: 19751941
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of metastasizing oligodendroglioma: a case report.
Wang M; Murphy KM; Kulesza P; Hatanpaa KJ; Olivi A; Tufaro A; Erozan Y; Westra WH; Burger PC; Berg KD
J Mol Diagn; 2004 Feb; 6(1):52-7. PubMed ID: 14736827
[TBL] [Abstract][Full Text] [Related]
19. [Diffuse bone marrow metastasis of an anaplastic oligodendroglioma].
Nakamura O; Watanabe T; Nomura K; Nakajima T
No Shinkei Geka; 1985 Aug; 13(8):903-9. PubMed ID: 4058667
[TBL] [Abstract][Full Text] [Related]
20. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
Sathornsumetee S; Cheunsuchon P; Sangruchi T
World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]